The results will be published at 7:00 am CEST and followed by a live webinar with CEO Øystein Rekdal, CDO Graeme Currie and CFO Gjest Andreas Breistein at 2:30 pm CEST. 

The presentation and subsequent Q&A session will be held in English and may be viewed live at https://forms.office.com/r/7FV1WJGZgJ

A recording of the presentation will be made available on https://www.lytixbiopharma.com/investors/overview.html after the presentation.